These oncogenic pathways are highly enriched in the high-risk group with high expression of TGF-β, suggesting that they may have direct or indirect cross-links with TGF-β signaling in the progression of PAAD. This evidence concerns the gene TGFB1 and pancreatic adenocarcinoma.